SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zhang, P. Articles by Tenen, D. G. Search for Related Content PubMed PubMed Citation Articles by Zhang, P. Articles by Tenen, D. G. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 June 2002, Vol. 99, No. 12, pp. 4406-4412 HEMATOPOIESIS Induction of granulocytic differentiation by 2 pathways Pu Zhang, Erik Nelson, Hanna S. Radomska, Junko Iwasaki-Arai, Koichi Akashi, Alan D. Friedman, and Daniel G. Tenen From the Harvard Institutes of Medicine, Harvard Medical School; and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; both of Boston, MA; and Johns Hopkins University, Baltimore, MD.     Abstract Top Abstract Introduction Materials and methods Results Discussion References The CCAAT enhancer binding protein  (C/EBP) transcription factor plays a critical role in granulocytopoiesis. Mice with a disruption of the C/EBP gene demonstrate an early block in granulocytic differentiation, and disruption of C/EBP function is a common theme in many types of human acute myelogenous leukemia, which is characterized by a block in myeloid development. To characterize further the nature of this block, we derived cell lines from the fetal liver of C/EBP-deficient animals. These lines resembled morphologically the immature myeloid blasts observed in C/EBP/ fetal livers and did not express messenger RNA encoding early myeloid genes such as myeloperoxidase. Similarly, granulocytic markers such as Mac-1 and Gr-1 were not expressed; nor were erythroid and lymphoid surface antigens. Introduction of an inducible C/EBP gene into the line revealed that conditional expression of C/EBP induced the C/EBP family members C/EBP and C/EBP and subsequent granulocyte differentiation. Similar results were obtained when C/EBP/ cells were stimulated with the cytokines interleukin-3 and granulocyte-macrophage colony-stimulating factor, but not with all-trans retinoic acid, supporting a model of at least 2 pathways leading to the differentiation of myeloid progenitors to granulocytes and implicating induction of other C/EBP family members in granulopoiesis. (Blood. 2002;99:4406-4412) © 2002 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Recent findings have emphasized the role of lineage-specific transcription factors in regulating the differentiation of multipotential hematopoietic cells to specific lineages.1,2 Understanding the mechanisms of the differentiation of granulocytic cells is particularly relevant to understanding the mechanisms involved in the pathogenesis of acute myelogenous leukemia (AML), in which granulopoietic development is blocked at an early stage. One transcription factor that has been shown to be especially critical in granulocyte development is C/EBP. Although C/EBP is expressed in many tissues, in the hematopoietic system it is specifically expressed in granulocytic cells only.3,4 C/EBP is expressed in the earliest myeloid cells; subsequently, other C/EBP family members, such as C/EBP 3 and C/EBP,4 are induced during granulocytic differentiation. C/EBP regulates the promoters of a number of important granulocytic genes, including growth factor receptors such as the granulocyte colony-stimulating factor (G-CSF) receptor5 as well as primary granule proteins such as myeloperoxidase (MPO).6 Introduction of C/EBP into bipotential human myeloid lines induces granulocytic and blocks monocytic differentiation,4 while expression of C/EBP but not PU.1 into the murine myeloblast 32D line also leads to granulocytic maturation.7 Recent studies have demonstrated multiple mechanisms of inactivation of C/EBP function in cells from human patients with AML. For example, a significant number of patients with the French-American-British M1 or M2 subtype harbor transdominant mutations in C/EBP.8 Patients with t(8;21) M2 AML do not harbor C/EBP mutations, but the AML1/ETO fusion protein encoded by the translocation results in down-regulation of C/EBP expression.9 Finally, in acute promyelocytic leukemia, C/EBP is not down-regulated; nor can mutations in C/EBP be detected.8,9 However, induction of the PML/RAR fusion protein encoded by the t(15;17) translocation in myeloid cell lines results in a marked decrease in C/EBP DNA binding activity (H.S.R., unpublished results, June 2001), and treatment of acute promyelocytic leukemia cells with all-trans retinoic acid (ATRA) results in induction of first C/EBP 10,11 and then C/EBP 12 as granulocytic differentiation is restored. In summary, these results not only further support the role of C/EBP in granulocytic development but demonstrate how inactivation of C/EBP can contribute to the granulocytic block characteristic of AML. Furthermore, they suggest that induction of C/EBP and C/EBP may also play important roles in granulocytic differentiation. A critical role for the function of C/EBP in granulopoiesis was demonstrated in mice harboring a disruption of the C/EBP gene.13 These mice show a selective early block in granulopoiesis, with the appearance of many myeloid blasts in fetal liver and peripheral blood.14 Other lineages, including macrophages, were not affected. These mice had a selective loss of granulocyte colony-forming units and interleukin-6 (IL-6) colony-forming units, which could be explained by the loss of expression of the G-CSF receptor and IL-6 receptor  (IL-6R).15,16 In addition, hematopoietic cells from these mice failed to express RNAs encoding primary or secondary neutrophil granule proteins, such as MPO or lactoferrin.16 Further studies demonstrated that at least in vitro, restoration of granulocytic differentiation could be effected by administration of the cytokines IL-3 and granulocyte-macrophage CSF (GM-CSF).15 These studies led us to propose a model in which at least 2 different molecular pathways, one involving C/EBP, and one involving these growth factors, could induce granulocytic differentiation of multipotential cells.15 Further characterization of the nature of the granulocytic block in C/EBP/ mice has been limited by a number of technical problems. First, because C/EBP regulates a number of liver genes involved in gluconeogenesis, the animals die shortly after birth from hypoglycemia.13 Therefore, studies of the C/EBP granulocytic cells are largely limited to fetal liver cells and peripheral blood of newborn mice. In addition, such studies are limited by the heterogeneity of available hematopoietic cells from the fetal livers of these mice. Therefore, to characterize further the nature of the granulocytic block in cells lacking C/EBP, we derived nontransformed cell lines from C/EBP fetal livers. Such lines resemble in many aspects the myeloid blasts from C/EBP/ fetal livers. Furthermore, like C/EBP/ fetal liver cells, either introduction of C/EBP expression or exposure to the cytokines IL-3 and GM-CSF induces expression of C/EBP and C/EBP and subsequent granulocytic differentiation. In contrast, ATRA fails to induce these other C/EBP family members and, as is the case with C/EBP/ mice in vivo,14 fails to induce granulocytic differentiation in the absence of C/EBP.     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Transduction of C/EBP/ fetal liver cells with HOX11 Fetal livers were isolated from pregnant C/EBP+/ mice (day 16 of gestation). Fetal livers that had no mature granulocytes in Diff-Quick-stained (Allegiance Health Care Laboratory Products, Bedford, MA) touch preps were assumed to be C/EBP/. Tail DNA was isolated to confirm the genotype by Southern blot analysis. Hematopoietic precursors were immortalized by infecting the cells with a retrovirus containing HOX11.17 Erythroid cells were lysed with ACK buffer, and hepatocytes were removed using a Falcon cell strainer. The remaining cells were cocultured overnight with the HOX11 retroviral producer cell line in the presence of 8 µg/mL polybrene in Iscoves modified Dulbecco medium (IMDM) supplemented with 20% heat-inactivated fetal calf serum, 1% WEHI-3B-conditioned medium as a source of IL-3,18 and 10% BHK-MKL as a source of stem cell factor (kindly provided by Schickwann Tsai and Ken Kaushansky). Twenty-four hours later, the supernatant containing the hematopoietic precursors was removed from the adherent producer cell line. These cells were cultured in fresh medium (as described above minus polybrene) for an additional 24 hours, at which time they were selected for retroviral integration with 400 µg/mL hygromycin B. In addition, culturing the cells in 400 µg/mL G418 eliminated any remaining producer cells; because the C/EBP/ mice were generated using a targeting construct containing G418 resistance, C/EBP/ cells were preferentially selected. After 2 months of continuous culture, individual clones were selected by limiting dilution. We were unable to isolate wild-type or heterozygous lines resembling the C/EBP/ lines. Cell culture conditions and cytokine induction of differentiation After establishment of C/EBP/ clonal lines, cells were grown in IMDM supplemented with 20% fetal calf serum, 1% WEHI-3B-conditioned medium, and 1% BHK-MKL-conditioned medium. To induce granulocytic differentiation with cytokines, both WEHI-3B- and BHK-MKL-conditioned medium were each increased to 10%, and murine GM-CSF (Genetics Institute, Cambridge, MA) was added to a final concentration of 15 ng/mL. Optimal morphologic differentiation was seen after 10 to 12 days. Other agents used in differentiation assays are as follows: recombinant human erythropoietin, 2 U/mL (Epogen, Amgen, Thousand Oaks, CA); recombinant human G-CSF, 2000 U/mL (Neupopgen, Amgen); 1.3 × 107 M tetradecanoyl phorbol acetate (TPA, Sigma, St Louis, MO); and 105 M ATRA (Sigma). Southern blot analysis for genotyping Cells were lysed 5 hours at 55°C in 10 mM Tris (pH 8), 100 mM NaCl, 10 mM ethylenediaminetetraacetic acid, 0.5% sodium dodecyl sulfate (SDS), and 100 µg/mL proteinase K. The DNA was extracted with phenol/chloroform and ethanol-precipitated. A total of 15 µg DNA was digested for 1 hour at 37°C with HincII and separated on a 0.8% agarose gel. DNA was transferred overnight in a solution of 0.4 M NaOH to a Biotrans (+) nylon membrane (ICN, Costa Mesa, CA) and immobilized with a Stratagene UV Stratalinker (La Jolla, CA). The membrane was prehybridized for 2 hours at 65°C in a 0.5 M NaPO4 (pH 7.2), 7% SDS, and 1% bovine serum albumin. Hybridization was performed overnight in the same solution using a random-primed labeled genomic fragment from the C/EBP gene.13 The membrane was washed twice in 2 × SSC, 0.2% SDS at 65°C for 10 minutes followed by 2 washes in 0.2 × SSC, 0.2% SDS at 65 degrees for 10 minutes. Analysis of expression of cell surface antigens Monoclonal antibodies to CD34, Gr-1, c-Kit, Ter-119, Thy1.2, Sca-1, CD8a, CD3, CD4, and streptavidin-phycoerythrin were obtained from PharMingen (San Diego, CA) and to Mac-1 and B220 from Caltag (Burlingame, CA). A total of 5 × 105 cells were washed with phosphate-buffered saline (PBS) and resuspended in PBS/5% bovine serum albumin containing labeled antibodies at concentrations recommended by the manufacturer. The cells were incubated at 4°C for 1 hour, washed in PBS, and analyzed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA). Establishment of stable cell lines harboring the C/EBP-ER fusion gene The stable cell line producing a retrovirus containing a C/EBP-estrogen receptor (C/EBP-ER) fusion construct has been previously described.7,19 We infected the 13/ line by cocultivation with the producer cells overnight in the presence of 8 µg/mL polybrene in the same growth medium as described above, except phenol red-free IMDM was used to reduce induction of fusion protein function. Twenty-four hours later, the transduced suspension cells were removed from the adherent producer cells. After another 24 hours, 400 µg/mL (active concentration) G418 was added to eliminate any remaining producer cells, and 1 µg/mL puromycin was added to select for retroviral integration. Independent clones were isolated via limiting dilution. Western blot analysis showed the presence of the C/EBP-ER fusion protein in 15% of the puromycin-resistant clones. One representative clone, 10/ER, was chosen for further study. For induction of functional C/EBP protein, 10/ER cells were incubated in medium containing 1.25 × 106 M -estradiol, dissolved from a stock of 10 mM -estradiol in ethanol. After 3 days, the cells were spun and resuspended in fresh -estradiol-containing medium. Control cultures were treated with vehicle only. Northern blot analysis Total RNA was isolated from stably transfected cell line by guanidium extraction (Tri-Reagent, Molecular Research Center, Cincinnati, OH) or by extraction followed by cesium chloride gradients20 and blotted onto Biotrans (+) (ICN). Blots were washed 2 times at 65°C with 1 × SSC/0.5% SDS for 5 minutes, followed by 0.1 × SSC/0.5% SDS twice for 30 minutes. Expression of the MPO gene was detected by a random-primed labeled complementary DNA fragment16 and of the IL-6R by a 1.6-kilobase SacI fragment of the murine IL-6R complementary DNA.21 As a loading control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) messenger RNA expression was determined with a random-primed labeled 1.3-kilobase PstI fragment of rat GAPDH complementary DNA.22 Western blot analysis of C/EBP proteins The 13/ and 10/ER cells were lysed by resuspending cell pellets in modified RIPA lysis buffer (50 mM Tris-HCl [pH 7.4], 1 mM ethyleneglycotetraacetic acid, 150 mM NaCl, 0.25% sodium deoxycholate, 1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, and 1 µg/mL each of pepstatin A, leupeptin, and aprotinin). An equivalent amount of protein was separated on 10% SDS-polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA), blocked in 5% nonfat dry milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T) for 1 hour at room temperature, and then incubated with primary antibodies in TBS-T (with 5% nonfat dry milk) for 1 hour at room temperature. C/EBP, C/EBP, and C/EBP proteins were detected with rabbit C/EBP polyclonal serum (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, cat. no. sc-61, recognizing amino acids 253 to 265 of rat C/EBP); a mouse monoclonal C/EBP antibody (1:4000; Santa Cruz Biotechnology, cat. no. sc-7962X, recognizing amino acids 199 to 345 of human C/EBP); and a rabbit polyclonal C/EBP antibody (1:5000; Santa Cruz Biotechnology, cat. no. sc-158X, recognizing a peptide mapping at the carboxyl-terminus of rat C/EBP); respectively, followed by an antirabbit or antimouse immunoglobulin G-horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, cat. no. sc-2004 and sc-2055). In some experiments, C/EBP was detected with a polyclonal anti-C/EBP antibody (1:3000 dilution of Santa Cruz Biotechnology sc-150X, recognizing amino acids 258 to 276 of rat C/EBP), which gave results similar to that of the monoclonal antibody. The retinoic receptor  (RAR) antibody was a rabbit polyclonal antibody (1:4000; Santa Cruz Biotechnology, cat. no. sc-551X, recognizing amino acids 443 to 462 of human RAR1). A monoclonal antimouse -tubulin antibody served as a loading control (Chemicon International, Temecula, CA).     Results Top Abstract Introduction Materials and methods Results Discussion References Establishment of early myeloid cell lines from C/EBP/ fetal liver A number of methods have been employed to isolate nontransformed cell lines from mice with targeted disruption of specific hematopoietic genes. Our initial attempts involved culturing C/EBP fetal liver cells from C/EBP/ mice in the presence of cytokines, such as stem cell factor, IL3, and/or GM-CSF. However, although such methods were recently used by several groups to isolate hematopoietic lines from PU.1-deficient animals,23,24 growth of C/EBP/ fetal liver cells under a variety of conditions only yielded mast cell cultures. We therefore used a second strategy derived from the findings that the HOX11 homeobox-containing transcription factor can immortalize murine hematopoietic precursors.17,25 C/EBP/ fetal liver cells were incubated in the presence of HOX11 retrovirus producer lines, and antibiotic selection was used to isolate cells that both contained the C/EBP knock-out targeting construct and the HOX11 retrovirus as described in "Materials and methods." We were only able to obtain lines in the presence of low concentrations of stem cell factor and IL-3; culture of HOX11-transduced cells in the absence of added growth factor was unsuccessful. These lines demonstrated a disruption in both alleles of the C/EBP gene identical to that observed in C/EBP/ knock-out mice (data not shown). The results obtained upon further analysis of several independent lines were similar to the ones presented with line 13/ described in detail below. We have reported that the C/EBP/ fetal liver cells can be differentiated to morphologically mature granulocytes in vitro in the presence of IL-3 and GM-CSF. To analyze further the mechanism of C/EBP-dependent and -independent granulocyte differentiation, we derived a cell line from the 13/ cells in which we could induce the expression of C/EBP. Following retroviral transduction of 13/ cells with a retrovirus encoding a C/EBP-ER fusion,7 independent clones were isolated by limiting dilution. Western blot analysis showed the presence of the C/EBP-ER fusion protein in 15% of the puromycin-resistant clones (Figure 1 and data not shown). One representative clone, 10/ER, was chosen for further study. View larger version (51K): [in this window] [in a new window]   Figure 1. Expression of the C/EBP-ER fusion protein in line 10-ER cells. Western blot analysis using a polyclonal antibody recognizing C/EBP was used to detect endogenous C/EBP or transfected C/EBP fusion proteins. Lane 1: A U937 line transfected with a metallothionein promoter C/EBP construct4 as a positive control; lanes 2-4: lysates from fetal liver cells of C/EBP/ and C/EBP+/ animals; lane 5: the 10-1ER line in which a C/EBP-ER fusion protein7 has been stably transfected; lane 6: the 13/ line. Shown on the right side are apparent molecular weight standards and, on the left, the position of migration of the C/EBP-ER fusion and endogenous C/EBP proteins. A number of smaller cross-reacting bands are observed in 10-1ER; this has been observed previously in lines expressing this plasmid.7,9 C/EBP/ cell lines resemble early myeloid blasts similar to those obtained from C/EBP/ mice We first asked whether the 13/ cells resembled the early myeloid blasts observed in C/EBP/ fetal livers and peripheral blood13 by assessing both cell surface analysis (Figure 2) and morphology (Figure 3). The morphology of both types of cells was very similar, having large nuclei with prominent nucleoli and a relative absence of granules in the cytoplasm (Figure 3A,B). View larger version (39K): [in this window] [in a new window]   Figure 2. The C/EBP/ and 10/ER lines express cell surface markers similar to that of C/EBP/ fetal liver hematopoietic cells. Cells were analyzed with monoclonal antibodies recognizing the stem cell markers Sca-1, c-Kit, and CD34, and myeloid markers Mac-1 and Gr-1. In each panel, the fluorescence with isotype control is shown as a dashed line and the specific antibody as a solid line along the x-axis (log scale) and relative number of cells on the y-axis. (A) C/EBP/ fetal liver hematopoietic cells; (B) 13/ cells; (C) 10/ER cells. View larger version (70K): [in this window] [in a new window]   Figure 3. The 13/ and 10/ER lines can differentiate into granulocytic and monocytic cells. Diff Quick staining of representative cytocentrifuged populations from (A) C/EBP/ fetal livers; (B) 13/ cells; (C) 13/ cells following granulocytic differentiation induced by increased IL-3 and GM-CSF; (D) 13/ cells following macrophage differentiation induced by TPA; (E) line 10/ER grown in vehicle only; (F) line 10/ER 6 days after treatment with -estradiol, which induces nuclear localization of the C/EBP-ER fusion protein and C/EBP function7,9; (G) line 10/ER treated with G-CSF only; and (H) line 10/ER treated with -estradiol and G-CSF. Original magnification, × 100. To assess further the characteristics of these cells, we compared surface expression of a number of hematopoietic cell surface markers to C/EBP/ fetal liver cells (Figure 2A) by flow cytometry. In terms of markers characteristic of early multipotential progenitors, 13/ cells expressed c-Kit but did not express murine CD34 (Figure 2B). The 13/ cells were negative for markers of more mature granulocytes, such as Gr-1 (Figure 2B). Interestingly, 13/ cells were positive for Mac-1, which is highly expressed on mature granulocytes and neutrophils. However, several studies have suggested that Mac-1 can be expressed on early stem cells, is then down-regulated, and then again up-regulated upon terminal myeloid differentiation.26-28 Similar results were observed with 10/ER cells stained with these markers (Figure 2C). The 13/ cells, as well as 10/ER, were negative for T- and B-cell markers and were negative for the panerythroid marker TER119 (data not shown). Therefore, the cells did not appear to have characteristics of stem cells or multilineage progenitors. We also measured the expression of the hematopoietic markers ER-MP12, ER-MP20, and ER-MP58, which recognize hematopoietic precursors and have previously been used as markers of monocytic differentiation.29-31 We could detect very low levels of ER-MP12, but not ER-MP20 or ER-MP58, on 13/ cells, consistent with an early myeloid phenotype (data not shown). In general, the pattern of surface expression of the 13/ cells was found to be similar to that of the hematopoietic cells from C/EBP/ fetal livers (Figure 2A)13 and consistent with a very early myeloid phenotype. C/EBP/ cells are bipotential; they can be specifically induced to either granulocytic or monocytic differentiation with different cytokines Previously, we had demonstrated that immature myeloid blasts isolated from C/EBP/ fetal livers were blocked in granulocytic differentiation in vivo but could be induced to differentiate into granulocytic cells in vitro following treatment with IL-3 and/or GM-CSF.15 Therefore, we asked whether C/EBP/ lines could differentiate into mature granulocytes following exposure to higher concentrations of IL-3 and GM-CSF. Ten days after increasing the concentration of WEHI-3B-conditioned medium from 1% to 10% and supplementing the medium with 15 ng/mL recombinant murine GM-CSF, several of the clones, including 13/, demonstrated marked granulocytic differentiation (Figure 3C) and an up-regulation of the granulocytic marker Gr-1 (data not shown). In addition, while 13/ cells expressed very low levels of the other C/EBP family members C/EBP and C/EBP, induction of differentiation with IL-3 and GM-CSF resulted in marked increases in both within 48 days, and this increase in C/EBP and C/EBP preceded the morphologic differentiation observed at 10 to 12 days (see below). Very little monocyte/macrophage differentiation was noted in the cultures; most of the cells resembled granulocytes, consistent with induction of Gr-1. Other putative granulocytic inducing agents, such as ATRA or G-CSF alone, failed to induce any differentiation of the cells. In addition to granulocytic differentiation potential, we were interested in seeing whether these cells could differentiate into other cell types. Attempts to induce erythroid differentiation using erythropoietin in combination with other cytokines were unsuccessful, as were attempts to induce B-cell differentiation using combinations of IL-7 plus growth on stromal cell lines supporting B-cell development, perhaps due to low levels of C/EBP.32 In contrast, we were able to induce monocytic differentiation of the C/EBP/ cells. TPA is a potent inducer of monocytic differentiation in bipotential myeloid lines, such as HL-60,33 U937,34 and K562.35 Therefore, we exposed the 13/ cells to 1.3 × 107 M TPA, a concentration that induces monocytic differentiation of these lines. After 4 days, the cells showed increased cytoplasm and demonstrated marked monocytic differentiation (Figure 3D), with no morphologic evidence for granulocytic differentiation. These results are consistent with the 13/ cells representing a very early bipotential myeloid precursor. Induced expression of C/EBP can restore granulocytic differentiation of C/EBP/ cells The fact that increased IL-3 and GM-CSF can induce granulocytic differentiation of 13/ cells suggested that their immature granulocytic phenotype was a result of loss of C/EBP only and not other genetic changes. The 10/ER cells, when grown in the absence of -estradiol, had a morphology (Figure 3E) and surface antigen expression pattern (Figure 2C) similar to that of the parental line 13/ as well as to C/EBP/ cells derived from C/EBP/ fetal livers14 (Figures 2A and 3A). The 10/ER cells were then tested for their ability to differentiate upon induction of functional C/EBP protein; 1.25 × 107 M -estradiol was added for induction. We have shown that under these conditions the fusion protein can be observed to translocate from the cytoplasm to the nucleus, accompanied by induction of C/EBP DNA binding activity.9 After 6 days of treatment with -estradiol, significant morphologic differentiation was seen in the 10/ER cells (Figure 3F). In addition, the cells stained positive for nitroblue tetrazolium (data not shown). Differential counts revealed that, as opposed to the untreated culture, in which no differentiated cells were observed, we could detect 30% bands, 28% segmented granulocytic cells, and 23% monocytic cells in the culture. Therefore, these results indicated that expression of functional C/EBP protein alone could induce myeloid differentiation of the C/EBP/ cells. While G-CSF by itself had no activity (Figure 3G), when used in combination with induction of exogenous C/EBP expression, granulocytic differentiation was slightly enhanced, with an increase in segmented granulocytes to 42% (Figure 3H). To assess further the induction of granulocytic differentiation, we also analyzed the expression of myeloid surface antigens in the 10/ER line. In general, the pattern of surface marker expression in uninduced 10/ER cells was similar to that observed in the parental 13/ line (Figure 2B-C). Both were CD34 and Gr-1 but Mac-1+. After induction of granulocytic differentiation following treatment with -estradiol, 10/ER cells demonstrated a dramatic up-regulation of the granulocytic marker Gr-1, similar to 13/ cells induced with IL-3 and GM-CSF (data not shown). To demonstrate that expression of C/EBP protein in the 10/ER cells could up-regulate C/EBP target genes, Northern blot analysis was performed before and after -estradiol treatment. Uninduced 10/ER cells are MPO- and IL-6R-negative. After induction, both of these genes are up-regulated (Figure 4A). A similar up-regulation of MPO RNA was noted in 13/ cells following granulocytic differentiation induced by IL-3 and GM-CSF (Figure 4B), while treatment of the 13/ cells with -estradiol alone did not lead to differentiation (see below) or induction of IL-6R RNA (data not shown). In addition, like we observed for 13/ cells induced with IL-3 and GM-CSF, induction of differentiation of 10/ER cells led to subsequent increases in C/EBP and C/EBP (see below). In summary, expression of functional C/EBP protein in C/EBP/ cells led to induction of a mature myeloid phenotype, as assessed by morphology, gene expression, and induction of cell surface antigens, demonstrating that the immature phenotype observed in C/EBP/ cells is a result of loss of C/EBP alone. View larger version (33K): [in this window] [in a new window]   Figure 4. Induction of myeloid gene expression following granulocytic differentiation in C/EBP-expressing and nonexpressing cells. (A) The 10/ER cells were differentiated following induction of C/EBP activity by treatment with -estradiol for the number of days as indicated above each figure. The Northern blot demonstrates induction of MPO and IL-6R. The blot was hybridized to GAPDH (bottom panel) as a control for RNA loading and integrity. (B) The 13/ cells were induced with IL-3 and GM-CSF for the number of days as indicated. The Northern blot demonstrates induction of MPO RNA. The blot was hybridized with GAPDH as a loading control as indicated. C/EBP and C/EBP are up-regulated in both C/EBP-dependent and -independent granulocytic differentiation pathways but not by ATRA As noted above, 13/ cells differentiated in response to restoration of C/EBP expression. In addition, treatment with IL-3 and GM-CSF also led to granulocytic differentiation in the absence of C/EBP in vitro, as we had previously observed with C/EBP/ fetal liver cells.15 However, treatment with ATRA failed to induce differentiation of C/EBP/ cells in vivo14 or in vitro15 and, also, as noted above, did not induce differentiation of 13/ cells. The availability of the 13/ line allowed us to begin to investigate the molecular mechanisms accounting for the ability of different conditions to induce granulocytic differentiation in the absence of C/EBP. Increased expression of C/EBP by itself can induce marked granulocytic differentiation of multipotential cell lines,11 32D cl3 granulocytic cells,36 or primary human CD34+ cells.44 Induced expression of C/EBP can also induce granulocytic differentiation of myeloid cell lines.12,37 Therefore, we asked whether ATRA, IL-3 plus GM-CSF, or induction of C/EBP expression in 13/ cells could induce expression of C/EBP and/or C/EBP. As shown in Figure 5A, treatment with ATRA, which did not induce granulocytic differentiation, failed to up-regulate either C/EBP or C/EBP protein levels. This failure to respond to ATRA was not due to decreased or absent RAR levels, because RAR protein was easily detected in untreated 13/ cells and was not down-regulated by ATRA (Figure 5A). In contrast, treatment of either 13/ cells (Figure 5B) or 10/ER cells (data not shown) with IL-3 plus GM-CSF strongly up-regulated C/EBP and C/EBP protein. In addition, induction of C/EBP expression and granulocytic differentiation of 10/ER cells following treatment with -estradiol also strongly up-regulated C/EBP protein, along with C/EBP to a lesser degree (Figure 6A). As a negative control for the induction of C/EBP expression in 10/ER cells, treatment of 13/ cells with -estradiol did not induce the expression of C/EBP and C/EBP and failed to induce granulocyte differentiation (Figure 6B). We conclude that conditions leading to granulocytic differentiation of C/EBP/ cells are associated with up-regulation of C/EBP<